Bone marrow imaging study for cancer and blood disorders
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at MRI scans of the bone marrow to better understand various cancers and blood disorders. It may help improve how these conditions are diagnosed and treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a cancer, blood disorder, or related condition.
- Your medical records and test results are available for review.
- You can give permission to take part (or a parent/guardian can for children).
- If you have a research MRI, you must be able to have an MRI safely.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new MRI technique called BoneMRI that may show bones more clearly than standard MRI. If you already need both a CT and an MRI of your spine, your scans could be used to compare this new method with the regular ones.
This study tests a new way to make MRI scans look like CT scans to find bone damage from multiple myeloma. You may join if you have just been diagnosed or if your disease came back after strong treatments, and you need bone imaging for staging.
This research study uses MRI scans (a safe imaging tool) to understand how bones, muscles, and joints work. Researchers are looking for both people with muscle or bone injuries and healthy volunteers to compare how the body moves and functions.
This study collects medical images (CT and MRI scans) and data from adults who are already having scans at the hospital. It creates a biobank to help researchers learn more about health and disease.
This study collects blood and bone marrow samples from patients with blood cancers to understand why treatments stop working. It aims to improve future treatments.
This study looks at how Crohn’s disease affects bones and bone marrow soon after diagnosis. It may help researchers understand disease effects and improve future care, either by comparing you to healthy controls or by tracking changes over time.
Hear when a new Hematologic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.